{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T18:14:37Z","timestamp":1725473677786},"publisher-location":"Chichester, UK","reference-count":50,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007743.pub2","type":"reference-entry","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T14:34:03Z","timestamp":1266417243000},"source":"Crossref","is-referenced-by-count":9,"title":["Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Karen A.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaide A","family":"Odelola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Saldanha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Mckoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,17]]},"reference":[{"key":"10.1002\/14651858.CD007743.pub2-BIB2|cit1","series-title":"Poster session presented at the American Thoracic Society International Conference 2005 May 20-25; San Diego, USA","article-title":"A phase IV study of the safety of Synagis\u00ae (Palivizumab) for prophylaxis of respiratory syncytial virus disease in children with cystic fibrosis","author":"Cohen","year":"2005"},{"key":"10.1002\/14651858.CD007743.pub2-BIB1|cit2","series-title":"Proceedings of the American Thoracic Society International Conference; 2005 May 20-25; San Diego, USA","first-page":"A178","article-title":"A phase IV study of the safety of Synagis\u00ae (Palivizumab) for prophylaxis of respiratory syncytial virus disease in children with cystic fibrosis [abstract]","author":"Cohen","year":"2005"},{"key":"10.1002\/14651858.CD007743.pub2-BIB3|cit3","unstructured":"American Academy of Pediatrics Committee on Infectious Diseases Policy Statement Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD007743.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0022-3476(88)80008-8","article-title":"Role of respiratory syncytial virus in early hospitalization for respiratory distress of young infants with cystic fibrosis","volume":"113","author":"Abman","year":"1988","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD007743.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1099-0496(199812)26:6<371::AID-PPUL1>3.0.CO;2-N","article-title":"Severe viral respiratory infections in infants with cystic fibrosis","volume":"26","author":"Armstrong","year":"1998","journal-title":"Pediatric Pulmonology"},{"issue":"10","key":"10.1002\/14651858.CD007743.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00006454-199910000-00006","article-title":"Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV Database. Pediatric Investigators Collaborative Network on Infections in Canada","volume":"18","author":"Arnold","year":"1999","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD007743.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/rmv.305","article-title":"Molecular epidemiology of Respiratory Syncytial Virus","volume":"11","author":"Cane","year":"2001","journal-title":"Reviews in medical virology"},{"key":"10.1002\/14651858.CD007743.pub2-BIB8|cit8","unstructured":"Cystic Fibrosis Foundation Newborn screening for cystic fibrosis http:\/\/www.cff.org\/GetInvolved\/Advocate\/NewbornScreening"},{"key":"10.1002\/14651858.CD007743.pub2-BIB9|cit9","unstructured":"Clinicaltrials.gov Current Studies on Motavizumab http:\/\/www.clinicaltrials.gov\/ct2\/results?term=motavizumab"},{"issue":"5","key":"10.1002\/14651858.CD007743.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jmv.20589","article-title":"Respiratory syncytial virus infection in a murine model of cystic fibrosis","volume":"78","author":"Colasurdo","year":"2006","journal-title":"Journal of Medical Virology"},{"key":"10.1002\/14651858.CD007743.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and Sample Size Calculations: A Review and Computer Program","volume":"11","author":"Dupont","year":"1990","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD007743.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/thx.39.2.150","article-title":"Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis","volume":"39","author":"Efthimiou","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD007743.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD007743.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00148581-200406030-00004","article-title":"Palivizumab: A review of its use as prophylaxis for serious respiratory syncytial virus infection","volume":"6","author":"Fenton","year":"2004","journal-title":"Pediatric Drugs"},{"issue":"2","key":"10.1002\/14651858.CD007743.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ppul.20751","article-title":"Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis","volume":"43","author":"Giebels","year":"2008","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD007743.pub2-BIB16|cit16","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"American Journal of Diseases in Children"},{"issue":"5","key":"10.1002\/14651858.CD007743.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1399-3038.2005.00298.x","article-title":"Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study","volume":"16","author":"Henderson","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"10.1002\/14651858.CD007743.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1542\/peds.103.3.619","article-title":"Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis","volume":"103","author":"Hiatt","year":"1999","journal-title":"Pediatrics"},{"issue":"7414","key":"10.1002\/14651858.CD007743.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistence in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007743.pub2-BIB20|cit20","unstructured":"Higgins JPT Altman DG (editors) Chapter 8: Assessing risk of bias in included studies Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org."},{"issue":"3","key":"10.1002\/14651858.CD007743.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD007743.pub2-BIB22|cit22","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007743.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1164\/ajrccm.154.5.8912759","article-title":"Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis","volume":"154","author":"Kirchner","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7568","key":"10.1002\/14651858.CD007743.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD007743.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00006454-200207000-00005","article-title":"Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999","volume":"21","author":"Leader","year":"2002","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD007743.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/adc.2006.0105338","article-title":"A survey of palivizumab for infants with cystic fibrosis in the UK","volume":"92","author":"McCormick","year":"2007","journal-title":"Archives of disease in childhood"},{"issue":"5","key":"10.1002\/14651858.CD007743.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.48.5.1811-1822.2004","article-title":"Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model","volume":"48","author":"Mejias","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD007743.pub2-BIB28|cit28","unstructured":"National Health Service Newborn Blood Spot screening across the UK\u00a0 http:\/\/www.screening.nhs.uk\/bloodspot-compare"},{"issue":"9","key":"10.1002\/14651858.CD007743.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.inf.0000086403.50417.7c","article-title":"Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants","volume":"22","author":"Pedraz","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD007743.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1203\/01.PDR.0000112244.72924.26","article-title":"Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats","volume":"55","author":"Piedimonte","year":"2004","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD007743.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/infdis\/165.1.166","article-title":"Respiratory syncytial virus infections in pediatric liver transplant recipients","volume":"165","author":"Pohl","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1002\/14651858.CD007743.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/01.inf.0000126273.27123.33","article-title":"Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002","volume":"23","author":"Purcell","year":"2004","journal-title":"Pediatric Infectious Disease Journal"},{"volume-title":"Red Book Drug Topics","year":"2009","author":"Physician's Desk","key":"10.1002\/14651858.CD007743.pub2-BIB33|cit33"},{"key":"10.1002\/14651858.CD007743.pub2-BIB34|cit34","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"4","key":"10.1002\/14651858.CD007743.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00431-002-1106-6","article-title":"Economic evaluation of possible prevention of RSV-related hospitalizations in premature infants in Germany","volume":"162","author":"Roeckl-Wiedmann","journal-title":"Eur J Pediatr"},{"key":"10.1002\/14651858.CD007743.pub2-BIB36|cit36","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) Bronchiolitis in Children: A National Clinical Guideline www.sign.ac.uk\/pdf\/sign91.pdf"},{"issue":"4","key":"10.1002\/14651858.CD007743.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.95.4.500","article-title":"Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls","volume":"95","author":"Sigurs","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD007743.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","article-title":"Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7","volume":"161","author":"Sigurs","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1002\/14651858.CD007743.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13","volume":"171","author":"Sigurs","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1002\/14651858.CD007743.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"34-42, 42.e1","DOI":"10.1016\/j.jpeds.2007.02.032","article-title":"Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing","volume":"151","author":"Simoes","year":"2007","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD007743.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.inf.0000069768.34383.18","article-title":"Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants","volume":"22","author":"Singleton","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD007743.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2006.05.008","article-title":"A survey of newborn screening for cystic fibrosis in Europe","volume":"6","author":"Southern","year":"2007","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1002\/14651858.CD007743.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/INF.0b013e3181673c15","article-title":"Use of palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis","volume":"27","author":"Speer","year":"2008","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"9178","key":"10.1002\/14651858.CD007743.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","journal-title":"Lancet"},{"issue":"42","key":"10.1002\/14651858.CD007743.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"35751","DOI":"10.1074\/jbc.M505832200","article-title":"Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections","volume":"280","author":"Tarran","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD007743.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD007743.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/adc.2008.139188","article-title":"Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus (RSV) infection","volume":"94","author":"Thorburn","year":"2009","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD007743.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1017\/S0950268803008926","article-title":"Hospitalization for respiratory syncytial virus in the pediatric population in Spain","volume":"131","author":"Vicente","year":"2003","journal-title":"Epidemiology and Infection"},{"issue":"26","key":"10.1002\/14651858.CD007743.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJM198412273112602","article-title":"Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis","volume":"311","author":"Wang","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1002\/14651858.CD007743.pub2-BIB50|cit50","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001725.pub2","article-title":"Immunoglobulin for preventing respiratory syncytial virus infection","author":"Wang","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007743.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T08:33:43Z","timestamp":1685435623000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007743.pub2"}},"subtitle":[],"editor":[{"given":"Karen A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,2,17]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007743.pub2","relation":{},"subject":[],"published":{"date-parts":[[2010,2,17]]}}}